Production assistance for cellular therapies (pact)- cell processing facilities
Ended Awarded Last action
- Contract number
- HHSN268201600013I
- Awardee
-
H. Lee Moffitt Cancer Center And Research Institute Hospital, Inc. UEI DVHKP4N619V9
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Task orders
- 7 $3,330,328 obligated
Award facts
- Opportunity
-
- NHLBI0ECBHB201609J Solicitation number
- Combined order value
-
- $3,330,328 Current, with exercised options
- $3,873,539 Potential, with all options
- Last date to order 100% complete
- IDV ceiling 7% used
- $45,630,651.00
- Maximum order
- $45,630,561.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- 10 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
Award details come from SAM.gov/FPDS.
About this IDV
The National Heart, Lung, and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health, awarded a multiple-award indefinite delivery contract valued at $45.6 million to H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., a nonprofit, National Cancer Institute-designated comprehensive cancer center located in Tampa, Florida. Established on July 29, 2016, with an ultimate completion date of June 30, 2022, this Production Assistance for Cellular Therapies - Cell Processing Facilities (PACT-CPF) master contract vehicle operates without small business set-asides and establishes a framework for cellular therapy manufacturing and process development services. All work is performed at Moffitt's facility in Tampa, Florida, leveraging the organization's substantial expertise in advanced cellular therapies, immunotherapy development, and translational medicine to support the federal government's broader objectives in advancing cellular therapy manufacturing capabilities and standardized processes within the research infrastructure.
Seven delivery orders have been issued under this master IDIQ contract, ranging from approximately $201,000 to $1.21 million, collectively valued at approximately $3.87 million. These delivery orders support specific cellular therapy research initiatives, including cryopreservation technical studies (PCT0005-02), Factor VIII T-cell receptor-engineered regulatory T cell product manufacturing (PCT0025-01), CD4+ central memory T cell expansion for allogenic hematopoietic cell transplantation (PCT0003-01), CD25-positive T-regulatory cell isolation and expansion services (PCT0003-02), and the LOVO PACT Center Study (PCT0002-02). All delivery orders utilize cost-no-fee or firm fixed-price pricing structures without set-asides, with completion dates ranging from March 2019 through June 2022. These awards represent the federal government's investment in specialized cell processing capabilities and manufacturing infrastructure essential to advance regenerative and cellular medicine initiatives under NHLBI sponsorship.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract HHSN268201600013I?
HHSN268201600013I was awarded to H. Lee Moffitt Cancer Center And Research Institute Hospital, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on July 29, 2016.
How much is contract HHSN268201600013I worth?
Orders under HHSN268201600013I have obligated $3,330,328. Their combined potential value, with all options, is $3,873,539. HHSN268201600013I's own ceiling is $45,630,651. A single order can be worth up to $45,630,561.
How many orders have been placed under contract HHSN268201600013I?
7 orders have been placed under HHSN268201600013I, the latest on June 3, 2019.
Who can order from contract HHSN268201600013I?
HHSN268201600013I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract HHSN268201600013I part of a contract vehicle?
Yes. HHSN268201600013I is part of Production Assistance for Cellular Therapies - Cell Processing Facilities (PACT-CPF).
Was contract HHSN268201600013I competed?
The government received 10 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV